Details of the Drug

General Information of Drug (ID: DMANM2B)

Drug Name

99mTc-EC-DG

Synonyms

EC-DG-[99mTc]; Technetium-99m-EC-DG; Technetium-99m-EC-G; Technetium-99m-EC-deoxyglucose; Technetium-99m-ethylenedicysteine-glucosamine; 99mTc-EC-G; 99mTc-EC-deoxyglucose; 99mTc-ethylenedicysteine-glucosamine; 99mTechnetium-EthylenediCysteine-n-acetyl-Glucosamine

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 3	[1]
------------------------------------------------------------------------------------

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C20H34N4O13S2Tc
Canonical SMILES: C(C[N-]C(C[S-])C(=O)NC1C(C(C(OC1O)CO)O)O)[N-]C(C[S-])C(=O)NC2C(C(C(OC2O)CO)O)O.O=[Tc+4]
InChI: 1S/C20H36N4O12S2.O.Tc/c25-3-9-13(27)15(29)11(19(33)35-9)23-17(31)7(5-37)21-1-2-22-8(6-38)18(32)24-12-16(30)14(28)10(4-26)36-20(12)34;;/h7-16,19-20,25-30,33-34,37-38H,1-6H2,(H,23,31)(H,24,32);;/q-2;;+4/p-2
InChIKey: XUWZVUPFDWQUTO-UHFFFAOYSA-L

Cross-matching ID

PubChem CID: 129711872
TTD ID: D00VQT

References

1	ClinicalTrials.gov (NCT01394679) A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer. U.S. National Institutes of Health.